A non-human primate model for human norovirus infection

• Published in: Nature microbiology Vol. 9; no. 3; pp. 776 - 786
• Main Authors: Rimkute, Inga, Chaimongkol, Natthawan, Woods, Kamron D., Nagata, Bianca M., Darko, Samuel, Gudbole, Sucheta, Henry, Amy R., Sosnovtsev, Stanislav V., Olia, Adam S., Verardi, Raffaello, Bok, Karin, Todd, John-Paul, Woodward, Ruth, Kwong, Peter D., Douek, Daniel C., Alves, Derron A., Green, Kim Y., Roederer, Mario
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.03.2024; Nature Publishing Group
• Subjects: 14/32; 14/63; 631/250/255/2514; 631/326/596/2555; 64; 82/1; 82/51; Animal models; Biomedical and Life Sciences; Biopsy; Cell surface; Epithelial cells; Gastrointestinal diseases; Glycosylation; Immune response; Infections; Infectious Diseases; Jejunum; Life Sciences; Medical Microbiology; Microbiology; Oral infection; Parasitology; Small intestine; Vaccines; Virology; Viruses
• ISSN: 2058-5276; 2058-5276
• DOI: 10.1038/s41564-023-01585-7

Norovirus infection can cause gastrointestinal disease in humans. Development of therapies and vaccines against norovirus have been limited by the lack of a suitable and reliable animal model. Here we established rhesus macaques as an animal model for human norovirus infection. We show that rhesus macaques are susceptible to oral infection with human noroviruses from two different genogroups. Variation in duration of virus shedding (days to weeks) between animals, evolution of the virus over the time of infection, induction of virus-specific adaptive immune responses, susceptibility to reinfection and preferential replication of norovirus in the jejunum of rhesus macaques was similar to infection reported in humans. We found minor pathological signs and changes in epithelial cell surface glycosylation patterns in the small intestine during infection. Detection of viral protein and RNA in intestinal biopsies confirmed the presence of the virus in chromogranin A-expressing epithelial cells, as it does in humans. Thus, rhesus macaques are a promising non-human primate model to evaluate vaccines and therapeutics against norovirus disease. Rhesus macaques are susceptible to oral challenge of human noroviruses and can be used as a model to recapitulate infection and adaptive immune responses in humans.